carteolol has been researched along with Diabetes Mellitus in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, H | 1 |
| Nakano, K | 1 |
| Yasuda, T | 1 |
| Komiyama, Y | 1 |
| Murakami, T | 1 |
| Nishimura, M | 1 |
| Nakanishi, T | 1 |
| Sakamoto, M | 1 |
| Nanbu, A | 1 |
| Yoshimura, M | 1 |
1 other study available for carteolol and Diabetes Mellitus
| Article | Year |
|---|---|
Anti-obesity and anti-diabetic effects of carteolol in non-insulin-dependent diabetic mice.
Topics: Adipose Tissue, Brown; Animals; Blood Pressure; Body Weight; Carbohydrate Metabolism; Cardiac Output | 1994 |